by admin | Nov 18, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Greg Slabodkin, ScienceBoard Editor in Chief The U.S. Food and Drug Administration (FDA) has elevated and reorganized its Office of Tissues and Advanced Therapies (OTAT) to a “Super Office” within the Center of Biologics Research and Evaluation (CBER) to meet its...
by admin | Nov 17, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
An experiment tests whether the gene-editing technology can stop the virus from replicating, which would ultimately wipe out the infection. By Wired.com In July, an HIV-positive man became the first volunteer in a clinical trial aimed at using Crispr gene editing to...
by admin | Nov 16, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
University of Edinburgh – Eurekalert.org Leprosy is one of the world’s oldest and most persistent diseases but the bacteria that cause it may also have the surprising ability to grow and regenerate a vital organ. Scientists have discovered that parasites...
by admin | Nov 16, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Jim Cornall – Labiotech.eu Sierra Space and University of California San Diego, one of the world’s top 15 research universities and a leader in microgravity research, have formed a new agreement with the goal of defining the future of human health care...
by admin | Nov 15, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
UK scientists have begun the first clinical trial of lab-grown red blood cells, with the hope that they survive longer in volunteers than donated blood cells. By Ed Cara – Gizmodo An important clinical trial is now underway in the UK. The study is the first to...
